Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年6月1日
	新闻
	BioNTech/ Genmab post early data for lung cancer therapy (NASDAQ:BNTX) Seeking Alpha BioNTech (BNTX) and Genmab (GMAB) announce positive initial results for acasunlimab in combination with Keytruda for lung cancer. Read more here. 标记为不相关
	Adagrasib Improves Survival, Responses in KRASG12C-mutated Advanced NSCLC OncLive Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection. October 23rd 2023 · Amivantamab Plus Lazertinib Improves ... 标记为不相关
	ASCO: BMS' KRAS confirmatory data leave FDA prospect unclear - Fierce Pharma Fierce Pharma Related. Amgen's request for full approval of Lumakras in lung cancer denied by FDA. At least the BMS trial uses blinded independent central review ... 标记为不相关
	Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ... tylerpaper.com Data were reported from 173 patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) who were treated with taletrectinib. 标记为不相关
	Shirley Brunmier Obituary - CA - Daily Breeze Daily Breeze ... lung cancer since February. A 31 year Torrance resident, Shirley was born in Kansas City, Missouri and raised in the Grand Cooley area of ... 标记为不相关
	Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination ... - NTB Kommunikasjon NTB Kommunikasjon Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all reported cases. NSCLC starts in the cells ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈